Telix Pharma Ltd (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Telix Pharmaceuticals Ltd. - ADR: Is Infosys Ltd. worth buying?
Item: Telix Pharmaceuticals Ltd. - ADR
Rating: 1.51716675
Author: Trendlyne DVM scores

about

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tom...

10.86 0.34 (3.23%)

41.27% Fall from 52W High

100.6K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Telix Pharma Ltd (ADR) is on 21 May 2026 for the purpose of Telix Pharmaceuticals Ltd Annual General Meeting for 2026 See details

Not Eligible

Expensive Valuation

2.7 / 100

Technically Neutral

58.0 / 100

1Yr Price target upside is 101%

4 analysts

Telix Pharma Ltd (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Telix Pharma Ltd (ADR) Live Stock Price Today, Share Analysis and Chart

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tom...

41.27% Fall from 52W High

SWOT Analysis

Telix Pharma Ltd (ADR) Live Price Chart